Top 10 Companies in the Butyl Chloroformate Market (2026): Market Leaders Powering Global Chemistry

MARKET INSIGHTS

Global Butyl Chloroformate market size was valued at USD 127.5 million in 2024. The market is projected to grow from USD 134.2 million in 2025 to USD 189.7 million by 2032, exhibiting a compound annual growth rate of 5.1% during the forecast period.

Butyl Chloroformate is a key chemical intermediate, specifically an alkyl chloroformate, characterized by its molecular formula C5H9ClO2. This highly reactive compound is primarily used as a carboxylating and chloroformylating agent in organic synthesis. Its reactivity makes it indispensable for introducing the butyloxycarbonyl (Boc) protecting group, a fundamental step in the synthesis of complex molecules, particularly in the pharmaceutical sector for peptide coupling and the production of active pharmaceutical ingredients (APIs).

The market growth is driven by the sustained expansion of the pharmaceutical industry, where Butyl Chloroformate is a critical building block for drug discovery and development. Furthermore, its application in the agrochemical sector for manufacturing pesticides and herbicides supports demand. However, the market faces challenges due to the compound’s hazardous nature, requiring strict handling and storage protocols, which can increase operational costs. Geographically, the Asia‑Pacific region, led by China, is a dominant force due to its robust chemical manufacturing base. Key players such as BASF and Dezhou Guofu Chemical Co., Ltd. are central to the market’s supply chain, with their production capacities and technological expertise influencing global availability and pricing.

Butyl Chloroformate Market – View in Detailed Research Report

TOP 10 Companies in the Butyl Chloroformate Market

---

10️⃣ BASF SE

Headquarters: Ludwigshafen, Germany
Key Offering: High‑purity Butyl Chloroformate for pharmaceutical intermediates

BASF has long been a benchmark in specialty chemicals, leveraging its global R&D network to deliver consistent quality. Its production lines in Ludwigshafen and China maintain stringent purity controls, meeting the demands of regulatory authorities in both EU and US markets.

Sustainability Initiatives:

• Investing in low‑energy synthesis routes to reduce CO₂ footprint.
• Implementing closed‑loop water recycling in key plants.
• Partnering with pharmaceutical firms to develop greener protection strategies.

---

9️⃣ Dezhou Guofu Chemical Co., Ltd.

Headquarters: Dezhou, Shandong, China
Key Offering: Bulk supply of 99%+ purity grades for API manufacturing

With a production capacity exceeding 200,000 tonnes annually, Dezhou Guofu serves the fastest‑growing Asian pharmaceutical market. The company’s investment in advanced purification modules has lowered impurity levels, making it a preferred supplier for generics manufacturers.

Sustainability Initiatives:

• Adoption of phosgene‑free synthesis pathways to improve safety.
• Deployment of renewable energy sources across its manufacturing sites.
• Participation in regional circular‑economy pilots to recycle waste streams.

---

8️⃣ Ambeed, Inc.

Headquarters: New York, USA
Key Offering: Custom‑grade Butyl Chloroformate for research and small‑batch production

Ambeed’s boutique production model allows rapid turnaround for academic and biotech clients. The company’s focus on process flexibility enables it to meet niche purity specifications without compromising yield.

Sustainability Initiatives:

• Utilising green solvents in downstream purification steps.
• Implementing digital monitoring for real‑time safety compliance.
• Collaborating with universities to develop safer handling protocols.

---

7️⃣ Toronto Research Chemicals Inc.

Headquarters: Toronto, Canada
Key Offering: Analytical‑grade Butyl Chloroformate for laboratory use

Known for its rigorous quality assurance, Toronto Research supplies reagents to pharmaceutical research facilities across North America. Its focus on trace‑element control ensures that even the most demanding assays receive uncompromised materials.

Sustainability Initiatives:

• Reducing hazardous waste through process intensification.
• Engaging in carbon‑offset projects within Ontario.
• Providing safety training modules to clients worldwide.

---

6️⃣ Biosynth Ltd.

Headquarters: Zurich, Switzerland
Key Offering: Specialty Butyl Chloroformate for advanced API synthesis

Biosynth’s Swiss roots grant it access to high‑precision manufacturing infrastructure, enabling the production of ultra‑pure intermediates required for complex molecules.

Sustainability Initiatives:

• Adopting continuous flow chemistry to reduce solvent usage.
• Partnering with European green‑chemistry initiatives.
• Implementing lifecycle assessment for each batch.

---

5️⃣ Capot Chemical Co., Ltd.

Headquarters: Shanghai, China
Key Offering: Mid‑grade Butyl Chloroformate for agrochemical synthesis

Capot serves the growing pesticide market in Asia, offering cost‑effective grades that meet regional specifications while maintaining acceptable purity.

Sustainability Initiatives:

• Optimizing feedstock sourcing to lower environmental impact.
• Investing in waste‑heat recovery systems.
• Developing biodegradable polymer additives for downstream products.

---

4️⃣ Shanghai Bide Pharmatech Co., Ltd.

Headquarters: Shanghai, China
Key Offering: High‑purity Butyl Chloroformate for API intermediates

With a focus on precision chemistry, Shanghai Bide supports the burgeoning Chinese generics sector by delivering reagents that meet the strict regulatory thresholds of the China Food and Drug Administration.

Sustainability Initiatives:

• Implementing green‑energy solutions across its plants.
• Adhering to ISO 14001 environmental management standards.
• Engaging in local community safety outreach programs.

---

3️⃣ Hairui Chemical

Headquarters: Guangzhou, China
Key Offering: Standard‑grade Butyl Chloroformate for bulk agrochemical production

Hairui’s extensive distribution network supports large‑scale pesticide manufacturers across Asia, offering competitive pricing for high‑volume orders.

Sustainability Initiatives:

• Deploying advanced filtration systems to reduce airborne emissions.
• Partnering with regional NGOs to promote chemical safety.
• Adopting renewable energy sources for its production sites.

---

2️⃣ Matrix Scientific

Headquarters: Los Angeles, USA
Key Offering: Research‑grade Butyl Chloroformate for medicinal chemistry laboratories

Matrix Scientific’s focus on small‑batch, high‑purity reagents serves the innovation hubs of the United States, allowing rapid prototyping of novel therapeutics.

Sustainability Initiatives:

• Implementing real‑time monitoring of hazardous material usage.
• Engaging in carbon‑neutral shipping partnerships.
• Supporting academic research on safer chloroformate alternatives.

---

1️⃣ Simson Pharma Limited

Headquarters: New Delhi, India
Key Offering: Custom‑synthesis of Butyl Chloroformate for pharmaceutical intermediates

Simson Pharma’s integrated synthesis platform enables it to provide on‑demand, high‑purity reagents to Indian generics manufacturers, reducing lead times and ensuring regulatory compliance.

Sustainability Initiatives:

• Investing in green‑chemistry research to replace hazardous reagents.
• Implementing waste‑to‑energy systems within its production facilities.
• Collaborating with local governments to promote safe handling training.

---

Download FREE Sample Report: Butyl Chloroformate Market – View in Detailed Research Report

Get Full Report: Butyl Chloroformate Market – View in Detailed Research Report

Market Outlook

Over the next decade, the Butyl Chloroformate market will maintain a steady trajectory, driven by the steady rise of generic pharmaceuticals and the need for advanced agrochemicals. The emphasis on high‑purity grades will likely increase as regulatory agencies tighten safety thresholds, especially in the EU and US. Companies that can combine cost efficiency with rigorous safety protocols will capture the most value.

Future Trends

• Shift toward phosgene‑free production routes to mitigate safety risks.
• Growing demand for bio‑based polymer precursors that incorporate butyl carbonate groups.
• Expansion of custom synthesis services to support rapid drug development cycles.
• Increased collaboration between chemical manufacturers and pharma R&D teams to co‑develop safer intermediates.